WX [WuXi PharmaTech (Cayman)] 20-F: (Original Filing)

[WuXi PharmaTech (Cayman) Inc. Page INTRODUCTION 1 2 PART I. ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 27 ITEM 4A. UNRESOLVED STAFF COMMENTS 49 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 49 ITEM 6. DIRECTORS, SENIOR MANAGEMENT] [Execution Version Dated 16 February 2015 WUXI PHARMATECH (CAYMAN) INC. AS BORROWER WUXI APPTEC HOLDING COMPANY, INC. WUXI APPTEC, INC. WUXI APPTEC (BVI) INC. WUXI APPTEC (HONG KONG) LIMITED AS ORIGINAL GUARANTORS CITIGROUP GLOBAL MARKETS ASIA LIMITED AS COORDINATING ARRANGER AND CITICORP INTERNATIONAL LIMITED AS AGENT FACILITY AGREEMENT FOR US$165,000,000 SENIOR TERM AND REVOLVING LOAN FACILITY CONTENTS Clause Page 1.] [LIST OF SUBSIDIARIES Name Abbreviation Place of Incorporation WuXi AppTec (BVI) Inc. WXAT BVI British Virgin Islands WuXi AppTec Co., Ltd. WXAT PRC WuXi AppTec (Shanghai) Co., Ltd. WASH PRC Shanghai SynTheAll Pharmaceutical Co., Ltd. STA PRC WuXi AppTec (Suzhou) Co., Ltd. WASZ PRC WuXi AppTec (Tianjin) Co., Ltd. WATJ PRC WuXi AppTec Holding Company, Inc. AppTec Holding WuXi AppTec,] [Certification by the Chief Executive Officer I, Ge Li, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered] [Certification by the Chief Financial Officer I, Edward Hu, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered] [Section 906 of the Sarbanes-Oxley Act of 2002 Ge Li Chief Executive Officer EX-13.1 6 d796029dex131.htm EX-13.1] [Certification by the Chief Financial Officer Edward Hu Chief Financial Officer EX-13.2 7 d796029dex132.htm EX-13.2] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement No. 333-182917 on Form S-8 of our reports dated April 15, 2015, relating to the consolidated financial statements and financial statement schedule of Wuxi PharmaTech (Cayman) Inc. and its subsidiaries, and the effectiveness of Wuxi PharmaTech (Cayman) Inc. and its subsidiaries’ internal]

By | 2016-03-24T02:47:01+00:00 April 15th, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Read More

MPEL [Melco Crown Entertainment] 6-K: Deutsche Bank Trust Company Americas Trust & Securities

[Deutsche Bank Trust Company Americas Trust & Securities Services Global Equity Services April 8, 2015 DEPOSITARY RECEIPTS Depositary’s Notice of Annual General Meeting of Shareholders of Melco Crown Entertainment Limited (the “Company”): Issuer: Melco Crown Entertainment Limited / Cusip 585464100 Country: Incorporated in the Cayman Islands Meeting Details: Annual General Meeting of Shareholders of the Company on May 20, 2015] [MELCO CROWN ENTERTAINMENT LIMITED NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 20, 2015 Dear Shareholders, Company You are cordially invited to attend the Annual General Meeting of Shareholders of Melco Crown Entertainment Limited (the “ 1. 2. To re-elect each of the following directors: (a) Mr. Lawrence Yau Lung Ho as the executive director of] [Annual General Meeting of Shareholders (Name of ADR holder) (Number of ADRs held) Resolutions presented for consideration by the Annual General Meeting of Shareholders of Melco Crown Entertainment Limited (the “Company”) on May 20, 2015. Affirmative Negative Abstained ORDINARY RESOLUTIONS 1) 2) To re-elect each of the following directors:] [Form 6–K TABLE OF CONTENTS Voting Card MELCO CROWN ENTERTAINMENT LIMITED Geoffrey Davis, CFA Chief Financial Officer 3]

By | 2016-03-30T01:00:19+00:00 April 15th, 2015|Categories: Chinese Stocks, MPEL, Webplus ver|Tags: , , , , , |0 Comments
Read More

IDI [IDI] 10-K:

[] [BUSINESS CONSULTING SERVICES AGREEMENT This Business Consulting Services Agreement (the “Agreement”) is entered into effective as of October 13, 2014 (the “Effective Date”) by and between The Best One, Inc., a Florida corporation (the “Company”) and Marlin Capital Investments, LLC, a Florida limited liability company (the “Consultant”). Each of the Company and the Consultant are hereinafter a “Party” and collectively] [SUBSIDIARIES Name of Subsidiary State or Other Jurisdiction of Incorporation Name Under Which Subsidiary is Doing Business IDI Holdings, LLC Delaware Interactive Data, LLC Georgia Interactive Data Intelligence Tiger Media Global Limited British Virgin Islands Shanghai Tiger Shangda Investment Consulting Co. Ltd. China Shanghai Tiger Yaoyang Advertising Co., Ltd. China Tiger Media Investments Limited British Virgin Islands Tiger Media Limited] [INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT We consent to the incorporation by reference in the Registration Statements of Tiger Media, Inc. and subsidiaries (the “Company”) on Form S-8 (File No.333-177025), (File No. 333-188739) and (File No. 333-194952) of our report dated April 15, 2015, with respect to our audits of the consolidated financial statements of the Company as of December] [CERTIFICATIONS I, Peter W. H. Tan, certify that: (1) I have reviewed this Annual Report on Form 10-K of Tiger Media, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Derek Dubner, certify that: (1) I have reviewed this Annual Report on Form 10-K of Tiger Media, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATIONS I, Jacky Wang, certify that: (1) I have reviewed this Annual Report on Form 10-K of Tiger Media, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Tiger Media, Inc. April 15, 2015 Peter W. H. Tan Co-Chief Executive Officer EX-32.1 8 d846806dex321.htm EX-32.1] [TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Tiger Media, Inc. April 15, 2015 Derek Dubner Co-Chief Executive Officer EX-32.2 9 d846806dex322.htm EX-32.2] [TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Tiger Media, Inc. April 15, 2015 Jacky Wang Chief Financial Officer EX-32.3 10 d846806dex323.htm EX-32.3]

By | 2016-03-13T16:31:28+00:00 April 15th, 2015|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] 20-F: WuXi PharmaTech (Cayman) Inc. Page INTRODUCTION 1 2

[WuXi PharmaTech (Cayman) Inc. Page INTRODUCTION 1 2 PART I. ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 27 ITEM 4A. UNRESOLVED STAFF COMMENTS 49 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 49 ITEM 6. DIRECTORS, SENIOR MANAGEMENT] [Execution Version Dated 16 February 2015 WUXI PHARMATECH (CAYMAN) INC. AS BORROWER WUXI APPTEC HOLDING COMPANY, INC. WUXI APPTEC, INC. WUXI APPTEC (BVI) INC. WUXI APPTEC (HONG KONG) LIMITED AS ORIGINAL GUARANTORS CITIGROUP GLOBAL MARKETS ASIA LIMITED AS COORDINATING ARRANGER AND CITICORP INTERNATIONAL LIMITED AS AGENT FACILITY AGREEMENT FOR US$165,000,000 SENIOR TERM AND REVOLVING LOAN FACILITY CONTENTS Clause Page 1.] [LIST OF SUBSIDIARIES Name Abbreviation Place of Incorporation WuXi AppTec (BVI) Inc. WXAT BVI British Virgin Islands WuXi AppTec Co., Ltd. WXAT PRC WuXi AppTec (Shanghai) Co., Ltd. WASH PRC Shanghai SynTheAll Pharmaceutical Co., Ltd. STA PRC WuXi AppTec (Suzhou) Co., Ltd. WASZ PRC WuXi AppTec (Tianjin) Co., Ltd. WATJ PRC WuXi AppTec Holding Company, Inc. AppTec Holding WuXi AppTec,] [Certification by the Chief Executive Officer I, Ge Li, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered] [Certification by the Chief Financial Officer I, Edward Hu, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered] [Section 906 of the Sarbanes-Oxley Act of 2002 Ge Li Chief Executive Officer EX-13.1 6 d796029dex131.htm EX-13.1] [Certification by the Chief Financial Officer Edward Hu Chief Financial Officer EX-13.2 7 d796029dex132.htm EX-13.2] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement No. 333-182917 on Form S-8 of our reports dated April 15, 2015, relating to the consolidated financial statements and financial statement schedule of Wuxi PharmaTech (Cayman) Inc. and its subsidiaries, and the effectiveness of Wuxi PharmaTech (Cayman) Inc. and its subsidiaries’ internal]

By | 2016-03-24T02:48:18+00:00 April 15th, 2015|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Read More

MPEL [Melco Crown Entertainment] 6-K: (Original Filing)

[THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt If you have sold or transferred Melco Crown Entertainment Limited (Incorporated in the Cayman Islands with limited liability) (SEHK Stock Code: 6883) PROPOSALS FOR (1) RE-ELECTION AND APPOINTMENT OF DIRECTORS, (2) GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, (3) AMENDMENTS TO SHARE] [Form 6–K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED]

By | 2016-03-30T01:01:43+00:00 April 15th, 2015|Categories: Chinese Stocks, MPEL, SEC Original|Tags: , , , , , |0 Comments
Read More

HIMX [Himax Technologies] 20-F: (Original Filing)

[TABLE OF CONTENTS Page 4 CERTAIN CONVENTIONS 4 PART I 6 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 6 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 6 ITEM 3. KEY INFORMATION 6 3.A. Selected Financial Data 6 3.B. Capitalization and Indebtedness 8 3.C. Reason for the Offer and Use of Proceeds 8 3.D. Risk Factors 9 ITEM 4.] [Himax Technologies, Inc. List of Subsidiaries Subsidiary Jurisdiction of Percentage of Himax Technologies Limited ROC 100.0 % Himax Technologies Korea Ltd. South Korea 100.0 % Himax Semiconductor, Inc. ROC 100.0 % Himax Technologies (Samoa), Inc. Samoa 100.0 (1) % Himax Technologies (Suzhou) Co., Ltd. PRC 100.0 (2) % Himax Technologies (Shenzhen) Co., Ltd. PRC 100.0 (2) % Himax Display, Inc.] [Certification I, Jordan Wu, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification I, Jackie Chang, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification April 15, 2015 Jordan Wu, the President and Chief Executive Officer of Himax Technologies, Inc., and Jackie Chang, the Chief Financial Officer of Himax Technologies, Inc., each certifies that, to the best of his or her knowledge: 1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and 2. the information contained] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements (No. 333-137585 and No. 333-176863) on Form S-8 and the registration statements (No. 333-188253 and No. 333-189052) on Form F-3 of Himax Technologies, Inc. and subsidiaries of our reports dated April 15, 2015, with respect to the consolidated]

By | 2016-03-15T23:10:12+00:00 April 15th, 2015|Categories: Chinese Stocks, HIMX, SEC Original|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF NASDAQ NON-COMPLIANCE LETTER DUE TO DELAY IN FILING FORM 10-K Xi’an, China, April 15, 2015 – Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that the Company received a notification from the Nasdaq Stock Market (“Nasdaq”) informing the Company that since it] [805 King Farm Blvd. Rockville, MD 20850 / USA Nasdaq.com By Electronic Delivery to: bing@skystarbio-pharmaceutical.com; aorudjev@schiffhardin.com; scramer@skystarbio-pharmaceutical.com April 15, 2015 Mr. Bing Mei Chief Financial Officer Skystar Bio-Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road Gaoxin District, Xi’an Shaanxi Province, P.R. China Re: Skystar Bio-Pharmaceutical Company (the “Company”) Nasdaq Symbol: SKBI Dear Mr. Mei: 1 I am] []

By | 2016-03-27T15:23:59+00:00 April 15th, 2015|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

MPEL [Melco Crown Entertainment] 6-K: THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE

[THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt If you have sold or transferred Melco Crown Entertainment Limited (Incorporated in the Cayman Islands with limited liability) (SEHK Stock Code: 6883) PROPOSALS FOR (1) RE-ELECTION AND APPOINTMENT OF DIRECTORS, (2) GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, (3) AMENDMENTS TO SHARE] [Form 6–K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED]

By | 2016-03-30T01:02:54+00:00 April 15th, 2015|Categories: Chinese Stocks, MPEL, Webplus ver|Tags: , , , , , |0 Comments
Read More

HIMX [Himax Technologies] 20-F: TABLE OF CONTENTS Page 4 CERTAIN CONVENTIONS 4

[TABLE OF CONTENTS Page 4 CERTAIN CONVENTIONS 4 PART I 6 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 6 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 6 ITEM 3. KEY INFORMATION 6 3.A. Selected Financial Data 6 3.B. Capitalization and Indebtedness 8 3.C. Reason for the Offer and Use of Proceeds 8 3.D. Risk Factors 9 ITEM 4.] [Himax Technologies, Inc. List of Subsidiaries Subsidiary Jurisdiction of Percentage of Himax Technologies Limited ROC 100.0 % Himax Technologies Korea Ltd. South Korea 100.0 % Himax Semiconductor, Inc. ROC 100.0 % Himax Technologies (Samoa), Inc. Samoa 100.0 (1) % Himax Technologies (Suzhou) Co., Ltd. PRC 100.0 (2) % Himax Technologies (Shenzhen) Co., Ltd. PRC 100.0 (2) % Himax Display, Inc.] [Certification I, Jordan Wu, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification I, Jackie Chang, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification April 15, 2015 Jordan Wu, the President and Chief Executive Officer of Himax Technologies, Inc., and Jackie Chang, the Chief Financial Officer of Himax Technologies, Inc., each certifies that, to the best of his or her knowledge: 1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and 2. the information contained] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements (No. 333-137585 and No. 333-176863) on Form S-8 and the registration statements (No. 333-188253 and No. 333-189052) on Form F-3 of Himax Technologies, Inc. and subsidiaries of our reports dated April 15, 2015, with respect to the consolidated]

By | 2016-03-15T23:11:43+00:00 April 15th, 2015|Categories: Chinese Stocks, HIMX, Webplus ver|Tags: , , , , , |0 Comments
Read More

CYD [CHINA YUCHAI INTERNATIONAL] 20-F: (Original Filing)

[CHINA YUCHAI INTERNATIONAL LIMITED Page Certain Definitions and Supplemental Information 2 2 Part I Item 1. Identity of Directors, Senior Management and Advisers 4 Item 2. Offer Statistics and Expected Timetable 4 Item 3. Key Information 4 Item 4. Information on the Company 22 Item 4A. Unresolved Staff Comments 38 Item 5. Operating and Financial Review and Prospects 38 Item] [The particulars of the Company’s subsidiaries as at December 31, 2014 are set forth below: Attributable equity interests Name of company Jurisdiction Direct Indirect Guangxi Yuchai Machinery Company Limited People’s Republic of — 76.4 % Guangxi Yuchai Accessories Manufacturing Company Limited PRC — 76.4 % Guangxi Yulin Yuchai Accessories Manufacturing Company Limited PRC — 74.2 % Guangxi Yuchai Machinery Monopoly] [TO SECTION 302 OF THE SARBANES-OXLEY ACT I, Hoh Weng Ming, certify that: 1. I have reviewed this annual report on Form 20-F of China Yuchai International Limited (the “Company”); 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [TO SECTION 906 OF THE SARBANES-OXLEY ACT (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. TO SECTION 906 OF THE SARBANES-OXLEY ACT (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [Consent of Independent Registered Public Accountant Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-197287) pertaining to the Equity Incentive Plan of China Yuchai International Limited of our reports dated April 15, 2015, with respect to the consolidated financial statements of China Yuchai International Limited and the effectiveness of internal control over financial]

By | 2016-03-28T12:29:40+00:00 April 15th, 2015|Categories: Chinese Stocks, CYD, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar